CoChat

Clinical and Therapeutic Implications of Cancer Stem Cells

Clarke, Michael F. · 2019 · New England Journal of Medicine

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Interview with Dr. Michael F. Clarke on clinical and therapeutic implications of cancer stem cells. (09:15)Download Cancers arise in tissues that can replicate and self-renew. Like normal tissues, cancers can replenish themselves, grow, and metastasize because of stem cells that are similar to normal stem cells but seem to respond less well to environmental stop signals in their niche. Therapy that targets cancer stem cells may be the next avenue of cancer treatment.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmra1804280

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 357

Metadata

Authors
Clarke, M. F.
Affiliations
Institute for Stem Cell Biology and Regenerative Medicine (US)
Corresponding author
Clarke, Michael F.
Venue
New England Journal of Medicine
Published
2019-06-06
Volume
380
Issue
23
Pages
2237-2245
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2955641089
Cited by
355
References
75
Citations by year
2026: 17 · 2025: 26 · 2024: 63 · 2023: 61 · 2022: 78 · 2021: 56 · 2020: 45 · 2019: 9
FWCI
4.53
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
cancer stem cells, self-renewal, tumor microenvironment, metastasis, cancer therapy, stem cell niche
MeSH terms
Cell Self Renewal, Animals, Antineoplastic Agents, Cell Differentiation, Hematopoietic Stem Cells, Humans, Immunotherapy, Mutation, Neoplasms, Prognosis, Stem Cells, Neoplastic Stem Cells, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.